Evidence map›Paper›PMID 34191213›Full record

ArticleEuropean journal of hybrid imaging2020

Bottom-of-sulcus dysplasia: the role of

S U Berlangieri, R Mito, M Semmelroch, M Pedersen, G Jackson

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of hybrid imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

S U Berlangieri *Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia.
R Mito *Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia. remika.mito@florey.edu.au.ORCID https://orcid.org/0000-0003-3945-2293
M SemmelrochFlorey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
M PedersenFlorey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
G JacksonFlorey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
Florey Institute of Neuroscience and Mental Health · AUAustin Health · AUThe University of Melbourne · AU

Funding

National Health and Medical Research Council 1091593
6 · The paper itself

Abstract

purposeBottom-of-sulcus dysplasia (BOSD) is a type of focal cortical dysplasia and an important cause of intractable epilepsy. While the MRI features of BOSD have been well documented, the contribution of PET to the identification of these small lesions has not been widely explored. The aim of this study was to investigate the role of F-18 fluorodeoxyglucose (

methodsTwenty patients with BOSD underwent both

resultsPET detected hypometabolic abnormalities consistent with the seizure focus location in 95% (19/20) of cases. Focal abnormalities were detected on

conclusionOur findings show that

Indexed as

18F-FDG PETBottom-of-sulcus dysplasiaFocal cortical dysplasiaMRI

Identifiers

PMID34191213
PMCPMC8218059
OpenAlexW3110971138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.